Form 4 for AXR AMREP CORP.
Accepted 2022-07-15 00:00:00 ET · period of report 2022-07-13 · accession 0001104659-22-080225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-15 | 2022-07-13 | AXR | Vitale Christopher V | Pres, CEO | A - Grant | $0.00 | +8,000 | 94.0K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-13 | A | A | 8,000 | $0.00 | 94,000 | D | — | — | (F1) Grant of restricted stock under the AMREP Corporation 2016 Equity Compensation Plan. The restricted stock will vest as follows: 2,666 shares on July 13, 2023, 2,666 shares on July 13, 2024 and 2,667 shares on July 13, 2025, subject to the continued employment of Mr. Vitale by AMREP Corporation on each vesting date. |